Anixa Biosciences (ANIX) vs Milestone Pharmaceuticals (MIST)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Anixa Biosciences (ANIX) has outperformed Milestone Pharmaceuticals (MIST) over the past year, losing 28.2% versus a loss of 63.6%. Over five years, ANIX leads with a -32.8% price change compared with -87.2% for MIST. Anixa Biosciences is the larger company by market cap ($101.9 million vs $89.1 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ANIX | MIST |
|---|---|---|
| Share price | $2.93 | $0.7153 |
| Market cap | $101.86M | $89.05M |
| 1-day change | -0.68% | -5.53% |
| YTD return | -5.45% | -62.51% |
| 1-year return | -28.22% | -63.60% |
| 5-year return | -32.80% | -87.17% |
| EPS (TTM) | $-0.32 | $-0.68 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $5.46 | $3.06 |
| 52-week low | $2.32 | $0.7096 |
| Distance from 52-week high | -46.34% | -76.62% |
| Average volume | 300.47K | 1.39M |
| Shares outstanding | 34.76M | 124.50M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ANIX has outperformed MIST by 35.4 percentage points over the past year.
ANIX vs MIST FAQ
Which is bigger, Anixa Biosciences or Milestone Pharmaceuticals?
Anixa Biosciences (ANIX) is larger, with a market capitalization of $101.86M compared with $89.05M for Milestone Pharmaceuticals (MIST).
Which stock has performed better over the past year, ANIX or MIST?
ANIX returned -28.22% over the past 12 months, compared with -63.60% for MIST (price return, excluding dividends). Past performance does not predict future results.
Are Anixa Biosciences and Milestone Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.